• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EIF1AX 突变与 Hurthle 细胞癌。

EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, 925 Chestnut Street 6th Floor, Philadelphia, PA, 19107, USA.

Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, 1025 Walnut Street, 401 College, Philadelphia, PA, 19107, USA.

出版信息

Endocr Pathol. 2018 Mar;29(1):27-29. doi: 10.1007/s12022-017-9501-8.

DOI:10.1007/s12022-017-9501-8
PMID:28965201
Abstract

The EIF1AX gene is a novel cancer gene that has been reported in the tumorigenesis of papillary thyroid carcinoma, follicular variant papillary thyroid carcinoma, and anaplastic thyroid carcinoma. A 71-year-old woman presented with a right thyroid mass, which was follicular neoplasm on cytology. The fine needle aspirate of the nodule was examined by next-generation sequencing and found to harbor EIF1AX and TP53 mutations. Right thyroid lobectomy was performed with final pathology showing Hürthle cell carcinoma with capsular and vascular invasion. We report an EIF1AX mutation in a patient found to have Hürthle cell carcinoma.

摘要

EIF1AX 基因是一种新型的癌基因,已在甲状腺乳头状癌、滤泡状甲状腺癌和间变性甲状腺癌的肿瘤发生中被报道。一名 71 岁女性因右侧甲状腺肿块就诊,细胞学检查提示为滤泡性肿瘤。对结节的细针抽吸物进行下一代测序检查,发现存在 EIF1AX 和 TP53 突变。行右侧甲状腺叶切除术,最终病理显示具有包膜和血管侵犯的 Hurthle 细胞癌。我们报告了一例 EIF1AX 突变患者,该患者被发现患有 Hurthle 细胞癌。

相似文献

1
EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.EIF1AX 突变与 Hurthle 细胞癌。
Endocr Pathol. 2018 Mar;29(1):27-29. doi: 10.1007/s12022-017-9501-8.
2
Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.EZH1 突变在滤泡性甲状腺肿瘤诊断中的临床应用价值。
Hum Pathol. 2018 Nov;81:9-17. doi: 10.1016/j.humpath.2018.04.018. Epub 2018 May 1.
3
TERT, HRAS, and EIF1AX Mutations in a Patient with Follicular Adenoma.TERT、HRAS 和 EIF1AX 突变在滤泡性腺瘤患者中的检测。
Thyroid. 2018 Jun;28(6):815-817. doi: 10.1089/thy.2017.0504. Epub 2018 May 18.
4
Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules.甲状腺结节中EIF1AX突变的患病率及表型相关性
Endocr Relat Cancer. 2016 Apr;23(4):295-301. doi: 10.1530/ERC-16-0043. Epub 2016 Feb 24.
5
A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma.在一个组织学诊断为嗜酸细胞癌的甲状腺结节中鉴定出一种新的EIF1AX无义突变。
Endocrine. 2018 Nov;62(2):492-495. doi: 10.1007/s12020-018-1611-7. Epub 2018 Apr 26.
6
Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?在甲状腺细针穿刺中,嗜酸性细胞病变/肿瘤比滤泡性病变/肿瘤更能预测恶性肿瘤吗?
Diagn Cytopathol. 2006 May;34(5):330-4. doi: 10.1002/dc.20440.
7
Activating BRAF Mutations Detected in Mixed Hürthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland: Report of an Unusual Case and Review of the Literature.在甲状腺混合性许特耳细胞癌和多灶性乳头状癌中检测到的激活型BRAF突变:1例罕见病例报告及文献复习
Int J Surg Pathol. 2016 Sep;24(6):519-24. doi: 10.1177/1066896916639377. Epub 2016 Mar 21.
8
EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion.一名患有小梁腺瘤和细胞学不确定病变患者的EIF1AX基因c.338-2A>T剪接位点突变
Arch Endocrinol Metab. 2020 Apr;64(2):185-189. doi: 10.20945/2359-3997000000208. Epub 2020 Mar 27.
9
PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.嗜酸细胞性滤泡癌中的PTEN和TP53突变
Endocr Pathol. 2015 Dec;26(4):365-9. doi: 10.1007/s12022-015-9403-6.
10
Papillary Hürthle cell carcinoma (Warthin-like tumor) of the thyroid. Report of a case with fine needle aspiration findings.甲状腺乳头状许特莱细胞癌(沃辛样肿瘤)。1例细针穿刺结果报告。
Acta Cytol. 1998 Nov-Dec;42(6):1437-40. doi: 10.1159/000332181.

引用本文的文献

1
EIF1AX mutation in thyroid nodules: a histopathologic analysis of 56 cases in the context of institutional practices.甲状腺结节中 EIF1AX 突变:机构实践背景下的 56 例组织病理学分析。
Virchows Arch. 2024 Nov;485(5):859-867. doi: 10.1007/s00428-024-03914-5. Epub 2024 Sep 3.
2
EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles.EIF1AX 突变在甲状腺肿瘤中的研究:细胞学、组织病理学和共突变特征的回顾性分析。
J Otolaryngol Head Neck Surg. 2022 Nov 12;51(1):43. doi: 10.1186/s40463-022-00594-6.
3
EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion.
一名患有小梁腺瘤和细胞学不确定病变患者的EIF1AX基因c.338-2A>T剪接位点突变
Arch Endocrinol Metab. 2020 Apr;64(2):185-189. doi: 10.20945/2359-3997000000208. Epub 2020 Mar 27.
4
Mutation profiles of follicular thyroid tumors by targeted sequencing.通过靶向测序分析滤泡性甲状腺肿瘤的突变谱。
Diagn Pathol. 2019 May 10;14(1):39. doi: 10.1186/s13000-019-0817-1.
5
The role of EIF1AX in thyroid cancer tumourigenesis and progression.EIF1AX 在甲状腺癌肿瘤发生和进展中的作用。
J Endocrinol Invest. 2019 Mar;42(3):313-318. doi: 10.1007/s40618-018-0919-8. Epub 2018 Jul 2.
6
A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma.在一个组织学诊断为嗜酸细胞癌的甲状腺结节中鉴定出一种新的EIF1AX无义突变。
Endocrine. 2018 Nov;62(2):492-495. doi: 10.1007/s12020-018-1611-7. Epub 2018 Apr 26.